Cargando…
Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy
SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047023/ https://www.ncbi.nlm.nih.gov/pubmed/36980714 http://dx.doi.org/10.3390/cancers15061828 |
_version_ | 1785013818137509888 |
---|---|
author | Sorrentino, Luca Sileo, Annaclara Daveri, Elena Battaglia, Luigi Guaglio, Marcello Centonze, Giovanni Sabella, Giovanna Patti, Filippo Villa, Sergio Milione, Massimo Belli, Filiberto Cosimelli, Maurizio |
author_facet | Sorrentino, Luca Sileo, Annaclara Daveri, Elena Battaglia, Luigi Guaglio, Marcello Centonze, Giovanni Sabella, Giovanna Patti, Filippo Villa, Sergio Milione, Massimo Belli, Filiberto Cosimelli, Maurizio |
author_sort | Sorrentino, Luca |
collection | PubMed |
description | SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a margin of >1 mm is still required to avoid locoregional recurrence in patients with a low response to neoadjuvant treatment. The findings of the present study might also increase the rate of sphincter-preserving rectal surgery in patients with a close/microscopically positive distal margin and a major/complete response to neoadjuvant chemoradiotherapy. ABSTRACT: Background: The adequate distal resection margin is still controversial in rectal cancer treated by neoadjuvant chemoradiotherapy (nCRT). The aim of this study was to assess the impact of a distal margin of ≤1 mm on locoregional recurrence-free survival (LRRFS). Methods: Among 255 patients treated with nCRT and surgery at the National Cancer Institute of Milan, 83 (32.5%) had a distal margin of ≤1 mm and 172 (67.5%) had a distal margin of >1 mm. Survival analyses were performed to assess the impact of distal margin on 5-year LRRFS, as well as Cox survival analysis. The role of distal margin on survival was analyzed according to different tumor regression grades (TRGs). Results: The overall 5-year LRRFS rate was 77.6% with a distal margin of ≤1 mm vs. 88.3% with a distal margin of >1 mm (Log-rank p = 0.09). Only stage ypT4 was an independent predictor of worse LRRFS (HR 15.14, p = 0.026). The 5-year LRRFS was significantly lower in TRG3–5 patients with a distal margin of ≤1 mm compared to those with a distal margin of >1 mm (68.5% vs. 84.2%, p = 0.027), while no difference was observed in case of TRG1–2 (p = 0.77). Conclusions: Low-responder rectal cancers after nCRT still require a distal margin of >1 mm to reduce the high likelihood of local relapse. |
format | Online Article Text |
id | pubmed-10047023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100470232023-03-29 Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy Sorrentino, Luca Sileo, Annaclara Daveri, Elena Battaglia, Luigi Guaglio, Marcello Centonze, Giovanni Sabella, Giovanna Patti, Filippo Villa, Sergio Milione, Massimo Belli, Filiberto Cosimelli, Maurizio Cancers (Basel) Article SIMPLE SUMMARY: The adequate distal resection margin in rectal cancer patients after neoadjuvant chemoradiotherapy might be tighter than expected. Patients with a distal margin of ≤1 mm vs. >1 mm were compared: while a distal margin of ≤1 mm may be sufficient in case of major/complete response, a margin of >1 mm is still required to avoid locoregional recurrence in patients with a low response to neoadjuvant treatment. The findings of the present study might also increase the rate of sphincter-preserving rectal surgery in patients with a close/microscopically positive distal margin and a major/complete response to neoadjuvant chemoradiotherapy. ABSTRACT: Background: The adequate distal resection margin is still controversial in rectal cancer treated by neoadjuvant chemoradiotherapy (nCRT). The aim of this study was to assess the impact of a distal margin of ≤1 mm on locoregional recurrence-free survival (LRRFS). Methods: Among 255 patients treated with nCRT and surgery at the National Cancer Institute of Milan, 83 (32.5%) had a distal margin of ≤1 mm and 172 (67.5%) had a distal margin of >1 mm. Survival analyses were performed to assess the impact of distal margin on 5-year LRRFS, as well as Cox survival analysis. The role of distal margin on survival was analyzed according to different tumor regression grades (TRGs). Results: The overall 5-year LRRFS rate was 77.6% with a distal margin of ≤1 mm vs. 88.3% with a distal margin of >1 mm (Log-rank p = 0.09). Only stage ypT4 was an independent predictor of worse LRRFS (HR 15.14, p = 0.026). The 5-year LRRFS was significantly lower in TRG3–5 patients with a distal margin of ≤1 mm compared to those with a distal margin of >1 mm (68.5% vs. 84.2%, p = 0.027), while no difference was observed in case of TRG1–2 (p = 0.77). Conclusions: Low-responder rectal cancers after nCRT still require a distal margin of >1 mm to reduce the high likelihood of local relapse. MDPI 2023-03-17 /pmc/articles/PMC10047023/ /pubmed/36980714 http://dx.doi.org/10.3390/cancers15061828 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sorrentino, Luca Sileo, Annaclara Daveri, Elena Battaglia, Luigi Guaglio, Marcello Centonze, Giovanni Sabella, Giovanna Patti, Filippo Villa, Sergio Milione, Massimo Belli, Filiberto Cosimelli, Maurizio Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title | Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title_full | Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title_fullStr | Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title_full_unstemmed | Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title_short | Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy |
title_sort | impact of microscopically positive (≤1 mm) distal margins on disease recurrence in rectal cancer treated by neoadjuvant chemoradiotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047023/ https://www.ncbi.nlm.nih.gov/pubmed/36980714 http://dx.doi.org/10.3390/cancers15061828 |
work_keys_str_mv | AT sorrentinoluca impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT sileoannaclara impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT daverielena impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT battaglialuigi impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT guagliomarcello impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT centonzegiovanni impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT sabellagiovanna impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT pattifilippo impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT villasergio impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT milionemassimo impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT bellifiliberto impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy AT cosimellimaurizio impactofmicroscopicallypositive1mmdistalmarginsondiseaserecurrenceinrectalcancertreatedbyneoadjuvantchemoradiotherapy |